step ga investor day review
rais estim tp
increas lt ep growth
conjunct investor day rais lt
sustain annual ep growth rate rang next two
year ep grow even faster compani roll
new pbm ingeniorx realiz relat save
lt ep growth expect driven core earn growth
rest come capit deploy also expect lt annual
oper revenu growth rang
commerci busi growth target driver commerci
busi expect grow oper revenu mid high-singl
digit next five year oper margin project
vs expect growth driven
risk busi group retire busi profit improv
fee-bas busi expans specialti product servic
dental vision new supplement health product
govern busi growth target driver govern
busi expect grow oper revenu low-doubl digit
compound-annual-growth-rate next five year oper margin expect
vs medicaid busi see strong rfp
pipelin repres billion increment revenue growth opportun
expect grow rate well industri averag
rais est tp rais ep est
resp rais
tp prev base ep estimate
risk includ pick cost trend pbm roll-out disrupt etc
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
one nation lead health benefit compani
serv million peopl affili compani
includ million enrol famili health plan
price rate outperform target price analyst rice
profit tax
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
total debt capit
blue sky valuat equat roughli ep
estim driven acceler rate membership growth
improv star rate medicar advantag busi stabl
margin trend commerci busi better expect
margin trend individu aca-compli busi
grey sky valuat equat ep
estim driven potenti earn drag
compliant individu busi exposur unexpect
pick-up medic cost trend
 close
conjunct investor day rais long-term sustain ep growth
rate rang top implement ingeniorx high
singl digit low doubl digit rang previous next two year
anthem ep growth expect least compani benefit
save relat ingingeniorx roll-out compani expect roughli new
lt ep growth driven core earn growth remain
strong market share market
continu benefit strong market share state hold
blue brand licens compani averag commerci market share
across state market market leader state
close number two remain four anthem process billion
claim annual behalf member across individu small group larg group
nation segment includ govern busi cover averag
one everi three member doctor hospit care across
state market share help compani develop deeper relationship
posit anthem prefer partner care provid consid
busi growth perform strategi addit size scale
allow compani deliv best-in-class cost structur deliv competit unit
price util
figur uniqu posit market
despit strong competit posit exist market expect market
share grow compani focuss three key prioriti recruit
best-in-class talent right structur make right strateg
invest fact compani estim across board improv
commerci market share repres nearli billion addit oper revenu
compani
commerci busi expect grow oper revenu mid-to-high
single-digit next five year sustain strong oper margin expect
vs compani expect strong top-lin
growth margin expans driven growth risk busi growth
group retire busi profit improv compani fee-bas busi
expans compani specialti product servic dental vision
new supplement health product
respect expect growth commerci risk busi
disciplin particip market compani see path
profit sustain marketplac compani modestli expand presenc
individu busi expect prudent respect hix
particip go forward respect group fully-insur busi face
headwind shrink market deterior share last year
howev compani believ well posit determin
revers trend also grow recaptur market share note
maintain local group insur market share last five year compani
oper revenu would billion higher
expect competit posit commerci risk market
greatli enhanc ingeniorx roll-out way background ingeniorx roll-out
lower enterpris wide pharmaceut spend billion total spend
billion pharmaci drug cost current repres littl
medic spend commerci market pharmaceut spend reduct
magnitud expect meaning improv posit commerci
opportun group retire market
respect opportun group retire market note
strong intern pipelin primarili driven strong commerci client base
compani current provid medicar servic egwp product believ
group product offer client compel financi valu qualiti care
proposit result compani plan aggress effect educ
commerci client valu proposit increas particip group medicar
advantag addit deep histori strong relationship
larg number commerci client includ labor public sector current
outsourc group retire busi competitor final signific
pipelin age-in opportun compani state overal expect
sever million member opportun across market well signific growth
opportun non-anthem blue
compani believ go beyond state take advantag group
opportun partner non-anthem blue histor focus
group busi repres total market million member continu
grow high singl digit per year believ combin oper
platform blue local market posit custom relationship drive new
busi group
size nation
size market
past year grew group medicar advantag membership
end januari compani expect grow nearli
member end look ahead expect group
busi scale significantli next five year membership grow fourfold
pmpm translat revenu opportun
billion compani see long-term oper margin group busi
similar individu medicar advantag margin howev compani
note guidanc expect group medicar advantag lt
target margin level compani grow book busi expect
improv margin profil new member target margin rang first two
year contract improv medic cost perform popul
realiz fix cost leverag growth membership
abil control medic spend deep network discount improv
medic cost manag program help compani grow commerci fee
membership nearli million member improv market share past
five year compani market share improv driven new busi win
well industri lead retent rate howev compani note still
captur full revenu potenti varieti buy servic across commerci
fee busi instanc compani current experi substanti oper
gain differenti self-insur live fully-insur live take five
self-fund member equal oper gain contribut one fully-insur
commerci member focus narrow gap next five year
improv buy-up ancillari product servic continu focu
administr expens effici note biggest opportun narrow
oper contribut gap improv pharmaci retent rate compani
medic book busi
respect opportun dental vision busi market
note two specialti servic repres billion premium
compani penetr rate current low past
year made sizabl invest improv competit posit
offer develop effect go-to-market strategi sell product anthem
expect improv penetr rate product target industri
also focus develop new specialti product
ill nation indemn etc larg group nation account segment
compani believ product total market size billion
grow rate per year initi market reaction product
posit compani sale result alreadi exceed intern expect
also made invest standard clinic well-b solut
preset packag make easier employ better understand offer
charl martineau pm univers toronto figur antm opportun improv penetr specialti servic
opportun non-anthem blue
beyond collabor non- blue group opportun
also collabor blue develop high perform
network addit develop next gener member engag
platform anthem whole health connect compani believ
scale nation level
believ strong market share allow compani help provid make
transit fee-for-servic value-bas care acceler way shift
driven varieti provid collabor model includ account care
organ primari care physician specialist behavior health contract anthem
hospit integr system home physician
value-bas arrang million member attribut care provid
compani value-bas program deliv signific result drive better
outcom fewer inpati admiss lower er visit fewer rapid
improv qualiti care faster improv better complianc rate
wrap signific cost save reduc cost bln four year
compani initi transpar payment model enhanc data share
report reduc administr burden expect lead meaning
growth value-bas payment risk share fact compani expect
percentag medic spend rise
percentag spend relat risk share increas
deliv medic cost trend slightli midpoint origin
guidanc expect local group medic cost trend rang plu
minu basi point approxim expect trend driven unit
price remain result increas util
medicaid busi see strong rfp pipelin repres billion
increment revenu growth opportun roughli anthem medicaid revenu
current attribut higher acuiti complex special popul
howev next five year compani see shift pipelin higher
acuiti popul typic associ higher pmpm repres nearli
bln revenu growth opportun year experi serv
medicaid member current serv approxim seven million member
market second largest medicaid industri leader
serv individu complex special need compani rfp win
rate around compani medicaid growth also
fuel allianc non-anthem blue partnership compani care
provid partner current eight arrang continu see
futur opportun long-term recent cross shield north
carolina partnership award north carolina medicaid contract
statewid prove strength cross partnership help
opportun medicar advantag
began transit growth mode end year
medicar advantag member previou year compani continu
growth end year member track post
enrol growth compani believ medicar advantag product
competit competit medic pharmaci benefit also due
market-lead supplement benefit portfolio includ servic cover
tradit medicar dental vision hear fit remain
commit offer full product portfolio includ tradit hmo
ppo compani believ long term success medicar advantag requir
compani hmo product competit product addit
believ hmo plan design allow best outcom oper result long-run
strong partnership particip provid addit
over-the-count pharmaci benefit industri partnership
significantli expand flexibl enabl medicar advantag plan offer benefit
address social barrier health believ medicar advantag
plan went far term breadth valu compani benefit
area
addit see opportun medicar partner non- blue
compani alreadi roll partnership cross shield
minnesota expect go live mainehealth bcb louisiana
final compani also expect see signific increment valu medicar
busi launch ingeniorx improv price enabl compani
enhanc competit medicar advantag part product
final offer stand-alone part product portfolio competit premium
diversifi busi group segment creat address rise individu
healthcar marketplac driven individu buy market especi medicar
medicaid second theme drive creation dbg healthcar mindset shift
lifetim valu demonstr increas measur net promot score
around custom satisfact greater percentag revenu come lifetim
custom valu evidenc need close care gap captur accur
medic risk score third major market theme recogn challeng meet
individu need expect drive rise variou partnership
merger acquisit new entrant health space three theme
anthem view lead acceler comprehens person whole
person care greatest need movement chronic complex
condit experi data membership
three chronic condit drive everi dollar spent
dbg structur three divis clinic pathway deliveri advanc
analyt aim specialti health center compani clinic pathway
segment focus creat manag best practic clinic pathway
emphasi chronic care deliveri combin recent
acquisit focus palli end life care caremor health
focus wrap around exist provid network support primari care
provid manag chronic condit newest unit advanc analyt use
central data drive better care predict comprehens insight well
creat data asset monet
anthem acquisit criteria within dbg segment includ captur meaning
earn abil address signific need plan repres
medic spend potenti doubl digit growth year year
express three key theme allow ingeniorx platform
growth first competit pharmaci offer allow expand
servic exist medic client greater opportun win back
pharmacyif pharmaci carv addit expand servic within
given client expect improv client retent second intern
pbm allow compet stand-alone pharmaci busi outsid exist
footprint third ingeniorx open opportun creat new partnership
non-anthem plan offer pharmaci solut understand
plan posit tailor meet uniqu need market
ingeniorx launch integr drug trend report one key statist
report specialti drug spend paid medic side specialti
pharmaci spend project grow billion
advanc client specif analyt provid predict enabl ingeniorx
guarante specif cost structur per member per month acceler launch
bring solut client sooner let share
confid abil seamlessli transit member ingeniorx
commerci member begin transit ingeniorx second quarter
compani migrat medicaid busi state approv receiv
anthem medicar compliant membership transit part
last phase migrat overal compani expect complet transit
expect million save realiz ep
increment million track deliv million
run-rat valu full year ahead schedul
reiter ep guidanc includ
ep benefit relat ingeniorx repres y/i growth nearli
oper revenu compani commerci segment expect grow mid-
upper-singl digit compar govern segment expect
oper revenu grow low doubl digit compani project full
year commerci fulli insur membership growth rang member
fee-bas membership growth rang
addit third year row track outpac broader market
compani expect enrol growth exceed medicaid
compani expect end million live includ addit
live januari relat launch compani medicaid allianc cross
shield minnesota expect organ growth live
across exist medicaid market outlook yet includ
contribut recent nc medicaid contract expect go live
phase approach begin total govern segment enrol estim
approach million live end
charl martineau pm univers toronto figur guidanc revenu billion membership million
mid upper-singl digit compound-annual-growth-rate
respect busi mix note compani revenu exposur
commerci segment declin govern
segment exposur increas period
compani see oper revenu come govern segment
commerci segment remain come new busi
figur busi mix oper revenu segment
anticip medic loss ratio /- bp adjust
health insur fee moratorium two percentag point impact medic loss ratio outlook
consist y/i basi favor impact
improv perform medicaid off-set unfavor trend relat
margin normal individu busi signific growth medicar
advantag respect sg see ratio /- bp rang
hif repres roughli bp y/i drag compani expect sg ratio
includ impact hif compani note past
year compani made number acquisit new acquisit come
uniqu set highli embed system
start administr system compani reduc
number system use six major system
aim get two system new product roll compani say
six administr system cumbersom costli program need
done six system across state compani believ two system
allow improv speed market allow adjust product add new
one quickli current compani member destin
respect capit alloc compani plan spend greater
bln capital-expenditure toward growth capit toward foundat invest
 system migrat consolid autom vs growth
foundat
last five year brought back million share common stock
averag price go forward compani plan opportunist
respect capit deploy compani look alloc free cash flow
 reinvest busi free cash flow alloc buy-back
remain would alloc dividend
lt oper revenu growth margin segment
respect lt segment outlook oper revenu commerci busi
expect grow mid upper-singl digit compound-annual-growth-rate margin increas rang
improv margin reflect market share growth
increas penetr specialti clinic solut improv oper
perform within fee-bas busi
oper revenu govern busi expect grow low-doubl digit
compound-annual-growth-rate margin rang diversifi busi group
ingeniorx estim produc least billion combin revenu margin
rang ingeniorx margin expect lower
segment margin rang dbg margin expect higher addit
segment margin benefit fact revenu post
total revenu expect grow compound-annual-growth-rate addit margin
project increas rang result chang
long-term ep growth year-end half antm earn
growth driven capit deploy go forward antm emphasi grow
core busi anthem new long-term growth target assum oper gain
drive earn growth capit deploy drive growth
beyond
compani mention price
